Hepion Pharmaceuticals Inc
HEPA0.318USD
0.000
Market hours （ET）Quotes delayed by 15 min
884.99Market Cap
LossP/E TTM
Hepion Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-5.37K
-771.23%
Analyst Rating
--
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -5367.398, with a year-on-year change of -771.23%.
What is the net income of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its net income was -13.19M, with a year-on-year change of 73.04%.
What is the net margin of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was 179.71%, with a year-on-year change of --.
What is the Return on Equity (ROE) of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was -1301.53%, with a year-on-year change of -614.87%.
What is the Return on Assets (ROA) of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -133.88%, with a year-on-year change of -7.18%.
What is the operating profit of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -19.95M, with a year-on-year change of 55.93%.
What are the current assets of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its current assets were 1.61M, with a year-on-year change of -90.77%.
What are the total assets of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its total assets of Hepion Pharmaceuticals Inc were 1.61M, with a year-on-year change of -91.08%.
What are the total liabilities of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Hepion Pharmaceuticals Inc were 3.48M, with a year-on-year change of -67.85%.
What is the total equity of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its total equity of Hepion Pharmaceuticals Inc was -1.86M, with a year-on-year change of -125.59%.
What is the net operating income of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Hepion Pharmaceuticals Inc was -13.19M, with a year-on-year change of 73.04%.
What is the net investment of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its net investment of Hepion Pharmaceuticals Inc was -600.00K, with a year-on-year change of -4094.63%.
What is the net financing of Hepion Pharmaceuticals Inc?
According to Hepion Pharmaceuticals Inc's FY2024 earnings report, its net financing of Hepion Pharmaceuticals Inc was 4.35M, with a year-on-year change of -3.23%.
